1 INTRODUCTION (Page No. – 17)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 20)
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.4.3 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 27)

4 PREMIUM INSIGHTS (Page No. – 31)
4.1 BREAST RECONSTRUCTION: MARKET OVERVIEW
4.2 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2019
4.3 GEOGRAPHICAL SNAPSHOT OF THE BREAST RECONSTRUCTION MARKET

5 MARKET OVERVIEW (Page No. – 33)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of breast cancer
5.2.1.2 Increasing awareness
5.2.1.3 Reimbursements for breast reconstruction
5.2.2 RESTRAINTS
5.2.2.1 Clinical risks and complications of breast reconstruction procedures
5.2.2.2 Alternative non-surgical methods
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging markets
5.2.3.2 Development of 3D-printed implants
5.2.4 CHALLENGES
5.2.4.1 Product failures and recalls
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM
5.5.1 COVID-19 IMPACT ON THE BREAST RECONSTRUCTION MARKET

6 BREAST RECONSTRUCTION MARKET, BY PRODUCT (Page No. – 39)
6.1 INTRODUCTION
6.2 BREAST IMPLANTS
6.2.1 BREAST IMPLANTS MARKET, BY TYPE
6.2.1.1 Silicone implants
6.2.1.1.1 Silicone breast implants to dominate the breast implants market during the forecast period
6.2.1.2 Saline implants
6.2.1.2.1 Low cost of implants to drive market growth
6.2.2 BREAST IMPLANTS MARKET, BY SHAPE
6.2.2.1 Round implants
6.2.2.1.1 Round implants show the highest end-user demand and market growth
6.2.2.2 Anatomical implants
6.2.2.2.1 Increasing implant-based breast reconstruction procedure will support the market growth
6.3 TISSUE EXPANDERS
6.3.1 RISING NUMBER OF BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH
6.4 ACELLULAR DERMAL MATRIX
6.4.1 RISING NUMBER OF ACELLULAR DERMAL MATRIX BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH

7 BREAST RECONSTRUCTION MARKET, BY PROCEDURE (Page No. – 46)
7.1 INTRODUCTION
7.2 IMMEDIATE PROCEDURES
7.2.1 IMMEDIATE PROCEDURES HOLD LARGEST MARKET SHARE
7.3 DELAYED PROCEDURES
7.3.1 RISING AWARENESS WILL SUPPORT MARKET GROWTH
7.4 REVISION PROCEDURES
7.4.1 DISSATISFACTION AND AESTHETIC ISSUES DRIVE DEMAND FOR REVISION

8 BREAST RECONSTRUCTION MARKET, BY TYPE (Page No. – 50)
8.1 INTRODUCTION
8.2 UNILATERAL BREAST RECONSTRUCTION
8.2.1 UNILATERAL RECONSTRUCTION DOMINATES THE MARKET, BY TYPE
8.3 BILATERAL
8.3.1 APAC TO SHOW HIGHEST GROWTH IN THE MARKET FOR BILATERAL BREAST RECONSTRUCTION

9 BREAST RECONSTRUCTION MARKET, BY END USER (Page No. – 53)
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 HOSPITALS TO DOMINATE THE BREAST RECONSTRUCTION MARKET DURING THE FORECAST PERIOD
9.3 COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS
9.3.1 GROWING PREFERENCE FOR OUTPATIENT TREATMENT AND PROCEDURES OVER HOSPITAL CARE DRIVES MARKET GROWTH
9.4 COVID-19 ANALYSIS

10 BREAST RECONSTRUCTION MARKET, BY REGION (Page No. – 56)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US dominates the North American breast reconstruction market
10.2.2 CANADA
10.2.2.1 Increasing incidence of breast cancer will drive market growth in Canada
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Germany dominates the European breast reconstruction market
10.3.2 FRANCE
10.3.2.1 Rising geriatric population will drive market growth
10.3.3 UK
10.3.3.1 Rising incidences of breast cancer will support market growth
10.3.4 ITALY
10.3.4.1 Rising geriatric population in Italy to drive the market
10.3.5 SPAIN
10.3.5.1 R&D investments for the development of innovative drugs form a key growth driver in the Spanish market
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 China accounts for the largest share of the APAC market
10.4.2 JAPAN
10.4.2.1 Growing geriatric population to drive the market in Japan
10.4.3 INDIA
10.4.3.1 Market growth in India is primarily driven by the rising incidence of breast cancer
10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE (Page No. – 96)
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2019
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES AND APPROVALS
11.3.2 PARTNERSHIPS, COLLABORATIONS, MERGERS, AND AGREEMENTS
11.3.3 EXPANSIONS
11.3.4 ACQUISITIONS
11.3.5 OTHER DEVELOPMENTS
11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES (Page No. – 103)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 JOHNSON & JOHNSON
12.2 ALLERGAN
12.3 SIENTRA
12.4 POLYTECH HEALTH & AESTHETICS
12.5 GC AESTHETICS
12.6 SEBBIN
12.7 IDEAL IMPLANT INCORPORATED
12.8 ESTABLISHMENT LABS S.A.
12.9 INTEGRA LIFESCIENCES
12.10 LABORATORIES ARION
12.11 SILIMED
12.12 GUANGZHOU WANHE PLASTIC MATERIALS
12.13 CEREPLAS
12.14 HANSBIOMED
12.15 RTI SURGICAL HOLDINGS
12.16 SHANGHAI KANGNING MEDICAL DEVICE
12.17 PMT CORPORATION